ArticleOncoTargets and therapy2023

EZH2 Contributes to 5-FU Resistance in Gastric Cancer by Epigenetically Suppressing FBXO32 Expression [Retraction].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.